• Department of Cardiovascular Surgery of Gansu Provincial Hospital, Lanzhou 730000, P. R. China;
YOUTao, Email: syxzwk@126.com
Export PDF Favorites Scan Get Citation

Objective To evaluate the monitoring value of brain injury biomarkers in the patients during extracorporeal membrane oxygenation (ECMO). Methods We searched PubMed, EMbase, the Cochrane Library, CNKI, and CBM from inception of each database to May 2015 to identify randomized controlled trials, or case-control trials, or cohort trials of brain injury biomarkers predict brain injury during ECMO. Data were extracted independently by two reviewers. Meta-analysis was conducted using STATA 12.0 software. Results Four retrospective trials were included. The results showed that compared with patients without brain injury, the patients with brain injury had a higher level of S100B protein (P < 0.05). The incidence of major neurological events was higher for high neuron-specific enolase level patients than mild-to-moderate neuron-specific enolase level patients (85% vs. 29%, P=0.01). The incidence of brain injury was higher for normal glial fibrillary acidic protein level than patients with glial fibrillary acidic protein > 0.436 ng/ml (OR=11.5, 95%CI 1.3-98.3). Conclusions Brain injury biomarkers may be used as an indicator for earlier diagnosis of brain injury in patients during ECMO.

Citation: YOUTao, WANGXin-kuan, LIUXing-guang, HOUXiao-dong, DINGFan, YIKang. Brain Injury Biomarkers Monitoring for the Patients during Extracorporeal Membrane Oxygenation: A Systematic Review. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2016, 23(2): 168-172. doi: 10.7507/1007-4848.20160037 Copy

  • Previous Article

    Role of Alpha Adrenoceptor on Modulating Water in Lung of Severe Acute Pancreatitis Rat Model
  • Next Article

    Influence of FoxM1 Expression on Ras and CDK1 Expressions in Thyroid Papillary Carcinoma TPC-1 Cells